Skip to main content

Aurora Cannabis Inc(ACB-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low4.02
Day High4.02
Open:4.02
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Motley Fool
The 420 Failure: Here's the Real Reason Tilray Brands Has Been a Horrible Investment Despite Operating in a Legal Marijuana Market
Tipranks
Aurora Cannabis Buys EU GMP Producer Safari Flower Company in $26.5 Million Deal
Tipranks
Canada’s Aurora Cannabis (ACB) Looks Overseas As Domestic Market Goes Up in Smoke
Tipranks
Aurora Cannabis Buys Safari Flower to Boost EU GMP Supply for Global Medical Markets
Newswire.ca
Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets
Zacks Investment Research
Cannabis Stock ACB Down 19% YTD: Should You Buy the Dip?
Cannabis Stock ACB Down 19% YTD: Should You Buy the Dip?
Zacks Investment Research
Should Tilray Brands Be in Your Portfolio Post Q3 Earnings?
Should Tilray Brands Be in Your Portfolio Post Q3 Earnings?
Tipranks
Aurora Cannabis Earns Repeat Honour for Executive Gender Diversity
Newswire.ca
Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year
Motley Fool
Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom?
Tipranks
Aurora Cannabis to Spotlight Strategy at TD Cowen Conference, Closes Bevo Deal
Newswire.ca
Aurora to Participate in the TD Cowen 46th Annual Health Care Conference
Tipranks
Aurora Cannabis Restructures Bevo Agtech Stake With Preferred Share Deal
Newswire.ca
Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis
Newswire.ca
Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand
Zacks Investment Research
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release?
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release?
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Aurora Cannabis Earnings Call Highlights Medical-First Pivot
Tipranks
Aurora Cannabis Sets Up US$100 Million ATM Equity Program With TD Securities
Tipranks
Aurora Cannabis Launches US$100 Million At-the-Market Equity Program to Fund Growth
Tipranks
Aurora Cannabis Q3 Results Highlight Record Medical Revenue and Strategic Refocus on Core Markets
Motley Fool
Aurora Cannabis (ACB) Q3 2026 Earnings Transcript
Newswire.ca
Aurora Cannabis Announces Fiscal 2026 Third Quarter Results
Newswire.ca
Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program
Newswire.ca
Aurora Launches New European Websites, Showcasing Science-Backed Cannabis Leadership
Tipranks
Aurora Cannabis Sets February 4 Call to Discuss Q3 2026 Results
Newswire.ca
Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call
Newswire.ca
Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties
Tipranks
Aurora Cannabis Advances Powdery Mildew-Resistant Cannabis Into Production Trials
Zacks Investment Research
Curaleaf Announces Delaware Domestication Plan: How to Play the Stock?
Curaleaf Announces Delaware Domestication Plan: How to Play the Stock?
Newswire.ca
Aurora Achieves Significant Progress in Disease Resistance Research
Zacks Investment Research
Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings?
Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings?

Profile

Aurora Cannabis Inc is a Canada-based company engaged in the production and distribution of medical cannabis. The Company is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, home cultivation, wholesale and retail distribution. The Company's purpose-built facilities, which integrate technologies across all processes, are defined by automation and customization. The Company has a funded capacity of more than 500,000 kilograms per year, as well as sales and operations in 24 countries across 5 continents.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.